Pepti Microdose Review: The Microdose Costs More Than the Full Dose

Pepti sells semaglutide at $99 a month and tirzepatide at $199 a month, and states plainly that the price is the same at every titration dose. It also sells two products it calls a longevity microdose, at $149 and $229. We read the site in August 2026, and those four numbers are the whole review: at Pepti, the product with "microdose" in its name costs more than the molecule on its own.

This is an editorial review. Pepti is not a partner of ours, there is no affiliate link on this page, and it is not ranked on our GLP-1 microdose rankings hub.

Flat pricing, and what flat means to a low-dose buyer

Pepti's cost page is explicit: all doses, one flat monthly price, the same all-in figure at every titration step.¹ For someone titrating up on a standard schedule that is a genuinely good structure — no step-up when you move from 0.5 mg to 1 mg, no reprice when your prescriber raises you.

For someone deliberately staying low, it is the structure this site keeps warning about. A flat price means taking a quarter of the drug costs you exactly what taking all of it costs. You are buying a month of access, not an amount of medication, and the vial you barely touch is billed identically to the vial you finish. We take that apart at length in what microdosing GLP-1 actually costs, and it is the single question our cheapest semaglutide for microdosing ranking is built to answer.

At $99, flat still lands well. That is a low number for compounded semaglutide by any measure, and if you are microdosing off a full-price vial, a cheap full price is the next best thing to a low-dose price. Just be clear about which one you are buying.

The microdose SKUs cost more

Here is where it gets strange. Pepti's catalog carries two items explicitly named as longevity microdoses: a GLP-1 with B6 at $149 a month, and a GLP-1/GIP with B12 at $229. Both sit above the plain injectable of the same class — $50 above semaglutide's $99, $30 above tirzepatide's $199.

One honest qualification, because it matters: these are combination products. They carry a B vitamin the plain SKUs do not, so this is not a like-for-like comparison of the same medicine at two doses. Measured against Pepti's own combination injections — GLP-1 with B6 at $349, GLP-1/GIP with B12 at $469 — the microdose versions are dramatically cheaper, and on that reading the microdose line is doing exactly what a microdose line should.

Both readings are true. Which one applies to you depends on what you would otherwise have bought. If you came here for a B6 combination and want less of it, the microdose is a real discount. If you came here to take a small amount of semaglutide, the cheapest way to do that at Pepti is to buy the $99 semaglutide and take less of it — and the product with the word "microdose" on it is the more expensive route to the same place.

That is not a criticism of the pricing so much as a warning about the label. "Microdose" is a marketing category here, not a cheaper tier, and a shopper who filters on the word will pay more than one who ignores it.

A second price ladder nobody can buy

There is a genuinely unresolved thing in Pepti's production data and we are not going to smooth it over.

The pages for both molecules ship a per-dose price array — semaglutide from $299 at 0.25 mg up to $449 at 2.4 mg, tirzepatide from $349 at 2.5 mg up to $549 at 15 mg — that no component on the site renders. We searched every client bundle we could download and found nothing that consumes it. Meanwhile the cost page, the product page and three cross-sell surfaces all say $99 and $199, flat.

We file the rendered figures, because that is what a buyer sees, what the catalog object carries and what five surfaces agree on. But note what the dead ladder would mean if it ever went live: it is a genuine per-dose ladder, the thing this site spends most of its time asking providers for — and its cheapest rung, $299 for 0.25 mg, is three times the flat headline. We could not break the tie, because the site's checkout endpoint refuses to answer anything but a purchase request. So this is recorded as unresolved rather than resolved in Pepti's favor, and anyone about to spend money on the strength of the $99 should walk the intake to a real checkout screen first.

What else is on the shelf

Sixty-eight prescription items, pulled from the site's own bundle. Semaglutide and tirzepatide by injection, orally, and as drops; nasal sprays; a long peptide line; hormones; at-home blood panels.

Three items on it should be named, because a microdose shopper will see them in the same navigation. Retatrutide is sold here as an injectable at $399 a month; it has no FDA approval in any form, and our position on it does not change because someone put a price on it — see microdosing retatrutide. Melanotan II and IGF-1 LR3 are also on the catalog. None of the three is something this publication would put in front of a reader as an option to consider.

Two other lines are relevant to readers here and both are ones we have already looked at skeptically: oral and sublingual GLP-1, covered in do sublingual and troche microdoses work, and oral semaglutide, covered in microdosing Rybelsus. Pepti prices oral semaglutide at $249 a month and oral tirzepatide at $399 — two and a half times and twice the injectable versions of the same molecules, for routes with far worse absorption.

What the site says twice, differently

Where it operates. Four separate surfaces — a shipping page, a state-availability page, a providers page and the homepage title — say 36 states, and publish the list. The terms of service say 50. Four corroborating surfaces beat one line in a legal document, so treat 36 as the number and check your own state against the published list.

When you are charged. The how-it-works page says you pay nothing until a physician approves your treatment. The refund policy says payment is collected at checkout, before the provider reviews your intake. The refund policy governs, so assume you are charged first and refunded within five to ten business days if you are declined. There is no refund once medication ships.

Who is behind it

The pharmacy is never named — described only as independent FDA-registered 503A or 503B compounding pharmacies. For compounded product you will be drawing and measuring yourself, that fails the pharmacy item on our provider trust checklist, and it fails it in the way that matters most for a low-dose buyer: concentration accuracy is the whole basis of the unit arithmetic in how to reconstitute and measure a microdose.

Two prescribers are named with full bios and no NPIs. A medical director board-certified in family medicine, licensed in twenty-six named states, and a chief medical officer in internal medicine licensed in fifteen. Education and board certifications are published; neither NPI is, so neither credential can be checked against the national registry.

The corporate entity is pepti LLC at a Newark, Delaware suite that is a well-known registered-agent address rather than an operating site. Its certification seal resolves against the certifying body's own image host. Cancellation is any time, effective at the end of the billing cycle, with a pause of up to ninety days and no proration — a pause is the right shape for someone holding a low dose and stretching a vial.

The regulatory screen

The trading name and the legal entity both returned zero company-column matches in the FDA's live warning-letter index in August 2026.² The screen carried a positive control — an unrelated telehealth seller with a real 2026 letter — which returned correctly, so the zeros are evidence rather than a query that quietly stopped working.

One note in Pepti's favor: a search on the stem of its brand name returns dozens of letters issued to peptide sellers. Pepti is not among them. Being absent from a list your own name puts you next to is a better result than it sounds.

The thing no price structure fixes

No randomized controlled trial has tested below-label GLP-1 dosing — not for weight, not for glycemic control, not for safety. The only clinical literature addressing microdosing directly does so as a caution, describing a practice that grew out of compounding restrictions and rests on patient anecdote rather than tested protocol.³ A cheap flat rate makes an untested practice cheaper to attempt. It does not make it tested. Is microdosing GLP-1 legit or hype and does microdosing GLP-1 work are the honest answers.

The honest bottom line

$99 flat for compounded semaglutide is among the lowest published figures we track, and flat pricing across the titration range is a real convenience for anyone moving up a ladder. But this is a site about taking less, and on that question Pepti's answer is no: the price does not fall when the dose does, and the two SKUs branded as microdoses cost more than the molecule alone. Add an unnamed pharmacy, unverifiable prescribers, a second price ladder sitting unrendered in production, and a charge taken before a clinician has read your file.

For the same question answered differently, Auren Rx charges $50 a month less for its microdose than for its own standard semaglutide plan, and Vyvron prices microdosing as its own program and then bills it in four-week cycles labeled "/mo". Three companies, three structures, one question worth asking all of them before you pay.